Inside information, profit warning: Solteq Plc lowers its guidance regarding the comparable operating result

Solteq Plc issued an inside-information profit warning revising its 2025 guidance: comparable revenue guidance remains a slight decrease but the company now expects the comparable operating result to remain at the same level or improve, versus its prior expectation of a significant improvement. Excluding the divested healthcare software business, comparable revenue in 2024 was EUR 48,818 thousand and the comparable operating result EUR 710 thousand; management cited slightly weaker-than-expected customer demand and delayed decisions on several new projects as drivers of weaker year‑end profitability. The revision reduces near-term upside to earnings and signals demand softness in Solteq’s Nordic retail/energy/e‑commerce markets; the Financial Statements Bulletin for 2025 will be published on February 12, 2026.

Analysis

Solteq Plc issued an inside-information profit warning on December 17, 2025, revising 2025 comparable operating result guidance to "remain at the same level or improve" versus the prior expectation of a "significant" improvement. Comparable revenue guidance remains a slight decrease; management reports 2024 comparable revenue excluding the divested healthcare business at EUR 48,818 thousand and a 2024 comparable operating result of EUR 710 thousand. The guidance revision removes much of the near-term upside to operating earnings that investors had expected.

Management attributes the weaker-than-expected year-end result to slightly softer customer demand and delayed decision-making on several new customer projects, which directly pressured profitability. The company continues to operate across Nordic markets in retail, energy and e-commerce but has signaled that project cadence and client decision timing materially affected margins.

The statement is likely to produce moderately negative investor sentiment (sentiment_score -0.5) and some share-price pressure, while the market_impact_score of 0.35 implies limited market-wide contagion. Investors should await the Financial Statements Bulletin on February 12, 2026 for full FY2025 quantification and any further guidance adjustments before materially changing exposure.

Key Decisions for Investors

• Avoid initiating new long positions ahead of the Financial Statements Bulletin on February 12, 2026 and wait for confirmed FY2025 results and updated operating metrics
• Existing holders should consider partial hedging or trimming positions to limit downside from delayed projects and demand softness while monitoring backlog, new contract awards and project decision timelines
• Monitor management commentary for further guidance revisions and margin-driver disclosures and reassess conviction if the comparable operating result guidance is revised downward or revenue exceeds a materially larger decline than the stated "slight decrease"